BMS-986253

BMS-986253 · Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BMS-986253, covering 2024-06-11 to 2025-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Nivolumab Combined With BMS-986253 in HCC Patients [Phase 2]